SYROS PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
SYROS PHARMACEUTICALS, INC. had Accumulated Other Comprehensive Income of $49.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-27
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $49.00K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $263.00K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $102.00K.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$226.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-06-30 | $49.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $263.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $102.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$226.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$313.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$273.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$79.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | -$5.00K 10-Q · filed 2021-11-05 |
| 2021-06-30 | -$19.00K 10-Q · filed 2021-08-05 |
| 2020-03-31 | $3.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $24.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $21.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $8.00K 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$3.00K 10-K · filed 2020-03-05 |
| 2018-09-30 | -$13.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$7.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$34.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$42.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | -$10.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$6.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$13.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$9.00K 10-K · filed 2018-03-12 |